1. Clinical Overview

L-Carnitine is a conditionally essential amino-acid derivative required for transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation and ATP production. At 600 mg/mL, LC-600 delivers clinically meaningful doses in low injection volumes, improving compliance and protocol efficiency.

2. Mechanisms of Action

2.1 Mitochondrial Fatty Acid Transport

Shuttles long-chain fatty acids across mitochondrial membrane, enables β-oxidation, prevents cytosolic fatty acid accumulation. Improved fat utilization and energy production.

2.2 ATP Production & Energy

Enhanced ATP generation, reduced reliance on glycolysis, improved metabolic flexibility. Greater stamina, endurance, reduced fatigue.

2.3 Metabolic Fatigue & Lactate Reduction

Reduced lactate buildup, improved recovery, enhanced ammonia clearance.

2.4 Insulin Sensitivity & Glucose Handling

Improved skeletal muscle glucose uptake, insulin signaling efficiency, metabolic adaptability during caloric restriction.

2.5 Neurocognitive & Mood Support

Neuronal energy metabolism, cognitive clarity, mood stability, mental fatigue reduction.

3. Evidence-Based Applications

3.1 Weight Loss & Body Composition

Fat oxidation, lean mass preservation, improved metabolic rate. Used alongside GLP-1 agonists, LC-series blends, caloric-deficit programs.

3.2 Exercise Performance & Recovery

Improved endurance, faster post-exercise recovery, reduced muscle soreness.

3.3 Chronic Fatigue & Low Energy

Chronic fatigue patterns, post-viral fatigue, mitochondrial dysfunction, burnout syndromes.

3.4 Metabolic Syndrome & Insulin Resistance

Glucose utilization, fat metabolism, improved metabolic markers.

3.5 Male Fertility & Androgen Support

Sperm motility, testicular mitochondrial function, hormonal health (indirect, adjunctive).

4. Administration & Dosing

Routes: IM (most common) • SC (acceptable for smaller volumes)
No reconstitution required — pre-mixed 600 mg/mL liquid formulation

Standard Metabolic: 500–1,000 mg, 1–2×/week
Weight Loss / Fat Oxidation: 1,000–2,000 mg, 1–3×/week
Performance / Athletic: 1,000–2,000 mg pre/post training, 1–3×/week
Chronic Fatigue / Mito Support: 500–1,000 mg, 2×/week
Duration: 6–12 weeks, may extend or repeat

Injection Volume Reference

Dose	Volume
300 mg	0.5 mL
600 mg	1.0 mL
1,200 mg	2.0 mL
1,800 mg	3.0 mL
2,400 mg	4.0 mL

Large volumes may be split between injection sites.

5. Clinical Decision Trees

Decision Tree 1 — Candidate Selection

Fatigue or low energy? → Yes

Difficulty losing fat? → Yes

Poor exercise recovery? → Yes

Insulin resistance? → Consider

Severe renal disease? → Avoid or reduce dose

Decision Tree 2 — Dose Selection

General wellness → 500–1,000 mg weekly

Weight loss → 1,000–2,000 mg weekly

Performance → 1,000–2,000 mg pre/post training

Fatigue syndromes → 500–1,000 mg 2×/week

6. Safety, Contraindications & Monitoring

Contraindications

Severe renal impairment
Known hypersensitivity
Pregnancy or lactation (precautionary)

Side Effects

Typically mild/dose-dependent: injection-site discomfort, mild nausea, fishy body odor (rare, high doses), headache, restlessness.

Monitoring

Energy levels
Exercise tolerance
Body composition
Blood pressure
Renal function (long-term high-dose)

Legal Disclaimer

This document is provided solely for educational and informational purposes. LC-600 is a compounded nutrient-based formulation not FDA-approved for weight loss or metabolic treatment. Peptide Protocol Portal makes no representations or warranties. By using this document, the reader agrees that Peptide Protocol Portal shall not be held liable. Use at your own risk.

References — LC-600 Clinical Reference Guide

Foundational Carnitine Biology

1. Bremer, J. Carnitine—metabolism and functions. Physiol Rev, 63(4), 1420–1480 (1983).

2. Rebouche, C. J. Carnitine function and requirements in humans. J Am Coll Nutr, 21(2), 159–166 (2002).

Metabolic & Weight Management

3. Malaguarnera, M. Carnitine in metabolic disorders and energy production. Clin Pharmacol Adv Appl, 4, 137–149 (2012).

4. Pooyandjoo, M., et al. Effect of L-carnitine on weight loss. Obesity Reviews, 17(10), 970–976 (2016).

Exercise Performance & Recovery

5. Sahlin, K. L-Carnitine and exercise metabolism. Sports Medicine, 52(1), 45–61 (2022).

6. Wall, B. T., et al. L-Carnitine and fat oxidation. J Physiology, 590(5), 1311–1324 (2012).

Insulin Sensitivity & Glucose

7. Mingrone, G. Carnitine in glucose metabolism and insulin resistance. Curr Opin Clin Nutr Metab Care, 7(4), 389–395 (2004).

Neurological & Fatigue

8. Jones, L. L., et al. Carnitine in neurological and cognitive energy metabolism. CNS Drugs, 24(2), 119–129 (2010).

LC-600 L-Carnitine 600 mg/mL